SUSAN BAZINET: Open Payments
NPI 1134150345 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 41 payments from 20 companies in 2025. Trend: 2023 $785 · 2024 $725 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $142 |
| Amgen Inc. | 1 | $119 |
| Merck Sharp & Dohme LLC | 4 | $112 |
| ABBVIE INC. | 4 | $70 |
| E.R. Squibb & Sons, L.L.C. | 3 | $64 |
| Geron Corporation | 2 | $58 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Celgene Corporation | 3 | $51 |
| ARRAY BIOPHARMA INC | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
Products named: IMDELLTRA (AMG757), KEYTRUDA, KISQALI, RYTELO, Nubeqa, EMRELIS, REBLOZYL, OPDIVO.
Industry payments across NC — which companies pay providers there.
